Beijing Airdoc Technology Co., Ltd. Stock

Equities

2251

CNE100004QQ9

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:08:17 2024-05-17 am EDT 5-day change 1st Jan Change
15.88 HKD +0.38% Intraday chart for Beijing Airdoc Technology Co., Ltd. +3.25% +31.24%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 340M 47M 367M Sales 2025 * 541M 74.9M 584M Capitalization 1.51B 209M 1.63B
Net income 2024 * -30M -4.15M -32.41M Net income 2025 * 25M 3.46M 27M EV / Sales 2024 * 1.64 x
Net cash position 2024 * 949M 131M 1.03B Net cash position 2025 * 949M 131M 1.03B EV / Sales 2025 * 1.03 x
P/E ratio 2024 *
-54.4 x
P/E ratio 2025 *
58.8 x
Employees 345
Yield 2024 *
-
Yield 2025 *
-
Free-Float 23.3%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.38%
1 week+3.25%
Current month-2.10%
1 month+4.06%
3 months+24.65%
6 months+35.49%
Current year+31.24%
More quotes
1 week
15.04
Extreme 15.04
16.06
1 month
14.04
Extreme 14.04
17.10
Current year
10.02
Extreme 10.02
18.38
1 year
7.88
Extreme 7.88
18.38
3 years
7.88
Extreme 7.88
74.95
5 years
7.88
Extreme 7.88
74.95
10 years
7.88
Extreme 7.88
74.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 15-09-08
Director of Finance/CFO 39 20-12-24
Corporate Secretary - 22-01-18
Members of the board TitleAgeSince
Chief Executive Officer 41 15-09-08
Director/Board Member 66 21-04-29
Director/Board Member 49 22-05-18
More insiders
Date Price Change Volume
24-05-17 15.88 +0.38% 206,100
24-05-16 15.82 -0.50% 126,300
24-05-14 15.9 +1.02% 105,300
24-05-13 15.74 +1.29% 168,600
24-05-10 15.54 +1.04% 97,500

Delayed Quote Hong Kong S.E., May 17, 2024 at 04:08 am EDT

More quotes
Beijing Airdoc Technology Co Ltd is a China-based company that provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company's main product is Airdoc-AIFUNDUS 1.0. The Company's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.7 CNY
Average target price
18.69 CNY
Spread / Average Target
+27.15%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW